News | Focused Ultrasound Therapy | April 05, 2016

Eight-minute video profiles patients with various diseases who have been helped by focused ultrasound therapy

April 5, 2016 — The Focused Ultrasound Foundation has produced a video that demonstrates the potential of this new medical technology to revolutionize the treatment of many serious disorders. The short film captures the experience and insights of patients, international researchers, physicians, industry leaders and other supporters of this “breakthrough transformational approach.”

The video features the story of Rick – a patient who felt embarrassed and inadequate because of his tremor. Rick’s outlook was transformed following focused ultrasound treatment at the University of Maryland. The video shows his challenges with conducting simple tasks, chronicles his treatment and captures him drinking steadily from a glass of water just minutes after the procedure — for the first time since childhood. “Focused ultrasound can give someone a new lease on life,” he stated.

Other patients profiled include:

  • Kimberly – a woman with Parkinson’s who is able to get back on her bike after treatment in a clinical trial;
  • Jack – a teenager who is able to play sports again thanks to the non-invasive treatment that eliminated pain caused by a bone tumor; and
  • Elizabeth – who regained her freedom after seeking relief from fibroid symptoms.

“Focused ultrasound treatment has given me back my life - it is a miracle,” said Parkinson’s patient Kimberly.

The 8-minute video also includes 15 experts talking about the potential of focused ultrasound from institutions like Stanford, the University of Virginia, Children’s National Medical Center and Sapienza University of Rome. Animation is used to demonstrate how beams of sound that harmlessly penetrate healthy tissue can be focused to treat a target deep in the body without incisions or other risks of traditional surgery. The therapy has the potential to transform treatment for a range of conditions, including Parkinson’s, Alzheimer’s, depression, pancreatic cancer, prostate cancer, hypertension and brain tumors.

Former National Cancer Institute (NCI) Director and Commissioner of the U.S. Food and Drug Administration (FDA) Andrew von Eschenbach, M.D., urges viewers to take action to support the technology. He closes the video with the statement, “Nothing happens in society unless people want it to. So when people stand up and say ‘we want this,’ then we will do it.”

For more information: www.fusfoundation.org


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now